Treatment of thromboangiitis obliterans by removal of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/44 (2006.01) A61P 9/10 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2721061

The invention relates to the use of a specific ligand for antibodies, preferably autoantibodies in the manufacture of a column for the treatment of thromboangiitis obliterans. The invention pertains furthermore to the apharesis column with at least one anti-1gG antibody for the treatment of thromboangiitis obliterans.

L'invention porte sur l'utilisation d'un ligand spécifique pour des anticorps, de préférence des auto-anticorps dans la fabrication d'une colonne pour le traitement de la thromboangéite oblitérante. L'invention porte de plus sur la colonne d'aphérèse avec au moins un anticorps anti-IgG pour le traitement de la thromboangéite oblitérante.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of thromboangiitis obliterans by removal of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of thromboangiitis obliterans by removal of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of thromboangiitis obliterans by removal of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1729705

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.